What is testosterone replacement therapy, and who is medically eligible in Europe?

Testosterone replacement therapy (TRT) explained: low testosterone (hypogonadism), symptoms, blood testing, risks, and prescribing criteria.

In this episode, we outline how TRT is assessed under EU medical guidelines and when treatment is clinically appropriate.

You’ll learn:

• The medical definition of low testosterone (confirmed by blood tests)

• Common symptoms: low libido, fatigue, reduced muscle mass, mood changes

• The importance of morning testosterone measurements

• Available forms: injections, gels, and transdermal preparations

• Potential risks, including erythrocytosis and prostate monitoring

• Fertility considerations and why TRT can suppress sperm production

• Situations where treatment requests may be declined without confirmed deficiency

We explain how doctors assess symptoms, repeat hormone testing, cardiovascular risk, sleep apnoea risk, prostate history, and fertility plans during an online consultation in the EU. TRT is not prescribed for age-related decline alone without documented hypogonadism.

This episode reflects the clinical standards used by Mobi Doctor, where hormone-related consultations are reviewed by a registered physician in line with EU prescribing guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/testosterone-replacement-therapy